arrow
P

Pilar Guerra-García

pediatric oncology and haematology department
H指数:12
被引数:360

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pre-emptive CYP2C19 genotyping and voriconazole exposure in pediatric hematology patients at risk of aspergillosis: an exploratory randomized pilot study with a cost-consequence analysis

CYP2C19基因分型预判和伏立康唑暴露在患有曲霉菌病风险的小儿血液科患者中的探索性随机试点研究:一项成本后果分析

2026-07-230
OAAI
Ex Vivo IL-15-Stimulated NK Cells as Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Leukemia

异体移植中用于儿童白血病的离体IL-15刺激的NK细胞作为过继细胞疗法

2025-08-080
PREAI
Tandem CD19/CD22 CAR T-cells as potential therapy for children and young adults with high-risk r/r B-ALL

串联CD19/CD22 CAR T细胞作为儿童和年轻高风险复发/难治性B-ALL的潜在治疗方法

2025-08-050
OA
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe
2024-01-018
PRE
CD19+lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation

CD19谱系嵌合体,在先前接受造血干细胞移植的患者中anti-CD19 car-t细胞治疗后的早期生物标志物

2022-08-082
OAAI
Advanced Molecular Characterisation in Relapsed and Refractory Paediatric Acute Leukaemia, the Key for Personalised Medicine

复发和难治性小儿急性白血病的高级分子表征,个性化医学的关键

2022-05-271
OAAI
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
2021-09-0126
OAAI
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium

新型冠状病毒肺炎在欧洲儿科早期癌症临床试验中的影响: 来自儿童癌症创新疗法 (ITCC) 联盟的报告

2020-12-0115
OAAI
High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers
2019-09-0729
OAAI